398 related articles for article (PubMed ID: 17167974)
1. Effect of immunotherapy and spleen preservation on immunological function in patients with gastric cancer.
Okinaga K; Iinuma H; Kitamura Y; Yokohata T; Inaba T; Fukushima R
J Exp Clin Cancer Res; 2006 Sep; 25(3):339-49. PubMed ID: 17167974
[TBL] [Abstract][Full Text] [Related]
2. Impact of spleen preservation in patients with gastric cancer.
Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
[TBL] [Abstract][Full Text] [Related]
3. Spleen preservation in radical surgery for gastric cardia cancer.
Zhang CH; Zhan WH; He YL; Chen CQ; Huang MJ; Cai SR
Ann Surg Oncol; 2007 Apr; 14(4):1312-9. PubMed ID: 17265118
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer.
Yu W; Choi GS; Chung HY
Br J Surg; 2006 May; 93(5):559-63. PubMed ID: 16607678
[TBL] [Abstract][Full Text] [Related]
5. The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer.
Oh SJ; Hyung WJ; Li C; Song J; Kang W; Rha SY; Chung HC; Choi SH; Noh SH;
J Surg Oncol; 2009 Apr; 99(5):275-80. PubMed ID: 19152367
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastasis at the splenic hilum in proximal gastric cancer.
Ikeguchi M; Kaibara N
Am Surg; 2004 Jul; 70(7):645-8. PubMed ID: 15279191
[TBL] [Abstract][Full Text] [Related]
7. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer.
Yamamoto M; Baba H; Kakeji Y; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T; Maehara Y
Hepatogastroenterology; 2004; 51(55):298-302. PubMed ID: 15011889
[TBL] [Abstract][Full Text] [Related]
8. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
Saito H; Kikkawa H; Bando H; Sakatoku M; Hirano M; Tatsuzawa T
Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
[TBL] [Abstract][Full Text] [Related]
9. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
10. Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma.
Li C; Kim S; Lai JF; Oh SJ; Hyung WJ; Choi WH; Choi SH; Zhu ZG; Noh SH
Eur J Surg Oncol; 2009 Jul; 35(7):709-14. PubMed ID: 18455906
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study on the efficacy of spleen-preserving modified D2 radical gastrectomy and D2 radical gastrectomy with splenectomy].
Yao XX; Yan C; Yan M; Li C; Chen J; Xiang M; Chen MM; Zhu ZG; Yin HR; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):111-4. PubMed ID: 20186620
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic pancreas- and spleen-preserving D2 lymph node dissection in advanced (cT2) upper-third gastric cancer.
Hur H; Jeon HM; Kim W
J Surg Oncol; 2008 Feb; 97(2):169-72. PubMed ID: 18095269
[TBL] [Abstract][Full Text] [Related]
13. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107
[TBL] [Abstract][Full Text] [Related]
15. [Impact of spleen preservation on the outcome of radical resection for cardia cancer].
Zhang CH; He YL; Zhan WH; Song W; Chen CQ; Cai SR; Huang MJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):531-4. PubMed ID: 18000773
[TBL] [Abstract][Full Text] [Related]
16. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
[TBL] [Abstract][Full Text] [Related]
17. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer.
Sasada S; Ninomiya M; Nishizaki M; Harano M; Ojima Y; Matsukawa H; Aoki H; Shiozaki S; Ohno S; Takakura N
Anticancer Res; 2009 Aug; 29(8):3347-51. PubMed ID: 19661354
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of suppressor cell activities in spleen cells from gastric cancer patients and the effect of splenectomy on prognosis of gastric cancer].
Toge T; Hamamoto S; Itagaki E; Nakane H; Yajima K; Hattori T
Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):961-4. PubMed ID: 6233481
[TBL] [Abstract][Full Text] [Related]
19. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival.
Wanebo HJ; Kennedy BJ; Winchester DP; Stewart AK; Fremgen AM
J Am Coll Surg; 1997 Aug; 185(2):177-84. PubMed ID: 9249086
[TBL] [Abstract][Full Text] [Related]
20. [Efficiency of D2 radical resection combined with splenectomy in T3 cancer of upper stomach].
Huang CM; Lu HS; Li P; Xie JW; Lin BJ; Zhang XF
Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):681-4. PubMed ID: 18956722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
